CVS Health (NYSE:CVS – Free Report) had its target price lifted by Evercore ISI from $60.00 to $65.00 in a research note released on Monday,Benzinga reports. The brokerage currently has an outperform rating on the pharmacy operator’s stock.
Several other brokerages also recently weighed in on CVS. Barclays lowered their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a report on Tuesday, December 3rd. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Mizuho cut their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. Finally, Royal Bank of Canada decreased their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $68.12.
CVS Health Trading Down 0.6 %
CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the company earned $2.21 earnings per share. Equities analysts forecast that CVS Health will post 5.22 earnings per share for the current fiscal year.
CVS Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.67%. CVS Health’s payout ratio is presently 67.51%.
Institutional Trading of CVS Health
Several institutional investors have recently made changes to their positions in the stock. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health during the 3rd quarter valued at $25,000. Livelsberger Financial Advisory acquired a new stake in CVS Health during the third quarter valued at $31,000. Legacy Investment Solutions LLC acquired a new position in CVS Health in the 3rd quarter worth about $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health during the 3rd quarter worth about $32,000. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health during the 3rd quarter valued at about $33,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Read More
- Five stocks we like better than CVS Health
- Election Stocks: How Elections Affect the Stock Market
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- How to Buy Cheap Stocks Step by Step
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Steel Stocks Soaring After Tariff Announcements
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.